The UK’s premier industrial biotechnology company Ingenza is working with the National Physical Laboratory and the University of Plymouth to develop a design and manufacturing platform for the production of a new family of antibiotics. The consortium has secured £933k…
Edinburgh-based Ingenza is celebrating after being named the Innovator of the Year at the 2017 Made in Scotland awards, held at the Glasgow Science Centre on the 19th of April. Now in its second year, the awards highlight the achievements…
Ingenza is pleased to announce that it will be hosting representatives of the Japanese government, academic and technology sectors later this month. The Japanese Ministry of Economy, Trade and Industry (METI) delegation will visit the company’s Roslin BioCentre site as…
Ingenza is celebrating reaching the final of both the Life Sciences Company of the Year and the Innovator of the Year categories at the 2017 Made in Scotland awards. Now in its second year, the awards highlight the achievements of…
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing…
Ingenza is using its proprietary inABLE® technology to help develop a robust, versatile platform for the production of cyclic peptides for therapeutic use. This work is part of a collaboration with researchers at the University of Aberdeen and the University…
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) feeding tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at…
Ingenza is collaborating with researchers at Plymouth University to develop an efficient, scalable microbial production system for epidermicin, an exciting new antibiotic that rapidly kills methicillin-resistant Staphylococcus aureus (MRSA) and other harmful bacteria. Mathew Upton, Associate Professor in Medical Microbiology…
Ingenza Ltd, a world leader in the application of industrial biotechnology and synthetic biology, is pleased to announce that it is collaborating with global healthcare company GlaxoSmithKline (GSK) on an innovative research project. A vital part of any collaboration is…